Progyny Stock: No Change To Long-Term Outlook (NASDAQ:PGNY)


Scientist looking in microscope at laboratory

Morsa Images/DigitalVision via Getty Images

Investment action

I recommended a buy rating for Progyny, Inc. (NASDAQ:PGNY) when I wrote about it in mid-March this year, as I continued to view the long-term growth outlook as attractive. Based on my current outlook and analysis, I recommend a

Leave a Reply

Your email address will not be published. Required fields are marked *